Form D · Other
Peerbridge Health, Inc.
New York, NY · CIK 0001629673
Offering snapshot reported Aug 15, 2025 · SEC filing
- Reported sold
- $7.18M Offering amount: $8M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- May 9, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2025 | Initial | $7,181,000 | No comparison | 25 | SEC filing |
| Jun 20, 2024 | Initial | $13,711,488 | No comparison | 28 | SEC filing |
| Feb 28, 2023 | Initial | $5,047,089 | No comparison | 26 | SEC filing |
| Oct 14, 2022 | Initial | $725,000 | No comparison | 4 | SEC filing |
| Feb 14, 2022 | Initial | $7,494,460 | No comparison | 24 | SEC filing |
| May 5, 2021 | Initial | $3,134,977 | No comparison | Not reported | SEC filing |
| Aug 25, 2020 | Initial | $2,655,000 | No comparison | 1 | SEC filing |
| Apr 2, 2020 | Initial | $393,667 | No comparison | 11 | SEC filing |
| Nov 5, 2019 | Initial | $10,949,433 | No comparison | 10 | SEC filing |
| Jun 4, 2018 | Initial | $1,475,000 | No comparison | 11 | SEC filing |
| Mar 23, 2017 | Initial | $1,725,000 | No comparison | 11 | SEC filing |
| Mar 31, 2016 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jan 7, 2015 | Amendment | $4,895,181 | $0vs Jan 6, 2015 | 7 | SEC filing |
| Jan 7, 2015 | Amendment | $4,895,181 | $0vs Jan 7, 2015 | 7 | SEC filing |
| Jan 6, 2015 | Initial | $4,895,181 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-554922
Source: Form D, filed Aug 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Angelo Acquista | Director |
| Angelo Aquista | Director |
| Todd Asmuth | Director, Executive |
| Mark Bakken | Director |
| Tamanna Bembenek, Ph.D. | Director |
| Arthur Bertolero | Director, Executive |
| Chris Darland | Director, Executive |
| Michael Fawkes | Director, Executive |
| Gregory Fontana | Director |
| Adrian Gilmore | Director, Executive |
| Patrick Horan | Director |
| Nicholas Jackson | Director |
| Avi Kometz | Director |
| Ari Kometz | Director |
| Richard Mulry | Director |
| Dan Reuvers | Director |
| Greg Tracy | Director |
Issuer details
Industry: Other (See others in industry)
Address:
3 Columbus Circle 15 Th Floor
New York, NY, 10019
New York, NY, 10019